NGM Biopharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NGM and other ETFs, options, and stocks.

About NGM

NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its lead product candidate, aldafermin, is designed for the treatment of patients with non-alcoholic steatohepatitis, with liver fibrosis stage 2, 3, or 4. 

CEO
David J. Woodhouse
CEODavid J. Woodhouse
Employees
225
Employees225
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2007
Founded2007
Employees
225
Employees225

NGM Key Statistics

Market cap
1.05B
Market cap1.05B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
428.51K
Average volume428.51K
High today
$13.29
High today$13.29
Low today
$12.65
Low today$12.65
Open price
$12.65
Open price$12.65
Volume
471.03K
Volume471.03K
52 Week high
$22.15
52 Week high$22.15
52 Week low
$10.49
52 Week low$10.49

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

NGM Earnings

-$0.59
-$0.39
-$0.20
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.